Author reply to "Heterologous mRNA-based COVID-19 booster strategies: Comment"
Hum Vaccin Immunother
.
2023 Dec 31;19(1):2195333.
doi: 10.1080/21645515.2023.2195333.
Epub 2023 Apr 4.
Authors
Rituparna Das
1
,
Randall N Hyer
2
,
Paul Burton
1
,
Jacqueline M Miller
1
,
Barbara J Kuter
1
Affiliations
1
Moderna, Inc, Cambridge, MA, USA.
2
Baruch S. Blumberg Institute, Doylestown, PA, USA.
PMID:
37014359
PMCID:
PMC10092875
DOI:
10.1080/21645515.2023.2195333
No abstract available
Grants and funding
This work was funded by Moderna, Inc.